A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients
Public ClinicalTrials.gov record NCT01376804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerability of up to 200 Days of Valganciclovir Oral Solution or Tablets in Pediatric Kidney Transplant Recipients
Study identification
- NCT ID
- NCT01376804
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 57 participants
Conditions and interventions
Interventions
- valganciclovir [Valcyte] Drug
Drug
Eligibility (public fields only)
- Age range
- 4 Months to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2011
- Primary completion
- May 30, 2013
- Completion
- May 30, 2013
- Last update posted
- Jul 10, 2017
2011 – 2013
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Florida Pediatric Nephrology | Gainesville | Florida | — | — |
| UCLA Center For Health Sciences; Division of Pediatric Nephrology | Los Angeles | Louisiana | 90095-1752 | — |
| Mount Sinai Medical Center | New York | New York | 10029-6574 | — |
| Uni of Utah Health Science Center; Pediatric Nephrology | Salt Lake City | Utah | 84108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01376804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01376804 live on ClinicalTrials.gov.